Abstract
In this study, we developed poly(lactide)-poly(ethylene glycol) (PLA-PEG) blend nanoparticles with variable molecular PEG weights (2, 10, or 20 kDa) to encapsulate antifungal amphotericin B (AmB) and to evaluate its in vitro efficacy in strains of Candida sp. and in vitro cytotoxicity in human erythrocytes. The nanoparticles were prepared using an emulsification/solvent evaporation technique and were characterized with respect to size, size distribution, AmB entrapment efficiency, AmB state of aggregation, and AmB in vitro release profile. The mean particle size was 241 nm, and AmB encapsulation efficiency was above 68.9%. The AmB in vitro release profile demonstrated a burst effect within the first 24 h, which released approximately 20% of AmB, followed by a sustained release of approximately 29.5% of AmB over 26 days. The nanoparticles protected the erythrocytes from lysis caused by AmB within the first 12 h, and AmB was efficacious against strains of Candida sp. in its sustained release profile. The PEG molecular weight did not demonstrate an effect on the physicochemical and biological parameters. Thus, PLA-PEG blend nanoparticles may function as potential carriers for AmB. Keywords: Amphotericin B, drug delivery, hemolysis, in vitro antifungal, polymeric nanoparticles.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
